To bring an end to the dollar hegemony one doesn’t need one common competing currency, but a number of national ones, according to former Ronald Reagan official and renowned American economist Dr
President Trump says he has “had it” with Zelensky, and leaks from Washington suggest that Zelensky go into exile, maybe to France. But is that the right approach to getting a Ukraine
More
The US government has moved to dismiss a long-running discrimination lawsuit against Elon Musk’s SpaceX, in which the Department of Justice (DoJ) had accused the rocket maker of unlawfully discriminating against asylum
More
by CIAGate To put it briefly, our records show that throughout his entire career, Liam Daniel Hayden carried out undercover operations across a wide range of locations. His secret missions took place
More
Sixty years ago today (Feb. 21), the world lost one of its most enigmatic and misunderstood figures: Malcolm X. His assassination on February 21, 1965, wasn’t just the silencing of a man—it
More
Civil rights attorney Ben Crump is calling on the Trump administration to declassify FBI and CIA files related to the assassination of Malcolm X. This plea comes as the nation marks the
More
by Our Correspondent in Washington, D.C. In a closely contested vote on Thursday afternoon, the Senate confirmed Kash Patel as the next Director of the Federal Bureau of Investigation (FBI), marking a
More
Ukraine has significantly exaggerated its rare-earth mineral reserves in an attempt to win favor with U.S. President Donald Trump, according to Bloomberg columnist and commodities expert Javier Blas. In an op-ed published
More
More than 60 years after the assassination of President John F. Kennedy, James Files, a former Chicago mob hitman, continues to claim that he was the one who fired the fatal shot.
More
John G. Trump, the influential scientist and engineer, has often been overshadowed by the larger-than-life presence of his nephew, Donald J. Trump, who, following a controversial and turbulent first term, has now
More
A proposed 25% tariff on pharmaceutical imports into the United States could have significant consequences for Indian drug manufacturers, potentially disrupting supply chains and increasing costs for American consumers, according to CNBC
More